Evidence map›Paper›PMID 42620682›Full record

ArticleFrontiers in medicine2026

Explainable and reliable kidney CT image classification using self-supervised DeiT-Tiny transformer.

Sai Sri Hemantha Konala, Srinivas Koppu

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sai Sri Hemantha KonalaSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Srinivas KoppuSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Kidney-related disorders are one of the global health concerns that require timely detection to prevent severe health complications. The use of computed tomography (CT) images for accurate classification of kidney diseases is important. However, it is challenging to differentiate between classes due to the subtle visual differences. This study introduces a novel two-stage deep learning architecture that integrates self-supervised representation learning with supervised classification for kidney CT image analysis using a publicly available kidney CT image dataset. Methods: In the first stage, the DINO framework with a Data-efficient Image Transformer (DeiT-Tiny) backbone is used to learn useful features from kidney CT images independent of labels. In the second stage, the pre-trained model is fine-tuned using labeled data to classify kidney abnormalities. To ensure model transparency and clinical trustworthiness, two explainable AI techniques are applied. Grad-CAM++ is used to highlight important regions contributing to predictions in kidney CT images. In addition, DINO's inherent multi-head self-attention mechanism is analyzed across all attention heads to capture diverse attention patterns. Results and discussion: Experimental findings indicate that the proposed framework achieves strong classification performance, with a test accuracy of 99.16%, AUC-ROC of 99.99%, F1 score of 98.97%, precision of 98.90%, and recall of 99.05%, while also providing clear interpretability for automated kidney disease classification. External validation on a CT dataset from Iraq has yielded 97.03% accuracy, supporting the generalizability of the proposed framework.

Indexed as

DeiT-Tiny transformerDINOGrad-CAM++kidney classificationself-supervised learning

Identifiers

PMID42620682
PMCPMC13485564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.